Agonist concentration influences the pattern and time course of intracellular Ca2+ oscillations in human arterial smooth muscle cells.
Oscillations in intracellular Ca2+ were recorded in cultured human uterine artery vascular smooth muscle cells. In the absence of external Ca2+, prolonged application of 3 microM histamine activated a large transient increase in Ca2+ followed by a burst of Ca2+ spikes. The time course and frequency of the spikes were approximately constant until the last two to three spikes, when the inter-spike interval progressively increased. At 30 microM histamine the response was different; the amplitude of the spikes decreased rapidly to zero, the rate of rise of successive transients fell and the time between spikes increased. The cessation of oscillatory activity was not associated with the depletion of intracellular Ca2+ stores, since increased doses of agonist or the sulphydryl reagent thimerosal could reactivate Ca2+ release. The changes in the pattern of intracellular Ca2+ spikes seen with increasing agonist concentration may reflect the involvement of different inactivation mechanisms in the termination of Ca2+ transients. In the presence of external Ca2+, histamine (3-30 microM) activated regular Ca2+ oscillations. The frequency, but not the amplitude, of the oscillations was dependent on agonist concentration, the highest frequency of spiking was observed at 30 microM histamine. In cells depolarised with 30 mM K+, histamine was still able to activate Ca2+ oscillations, but the dependence of spike frequency upon agonist concentration was abolished. Ca2+ oscillations could be activated in the presence of verapamil and nifedipine (10 microM). These data suggest that in human uterine artery vascular smooth muscle cells histamine-induced Ca2+ oscillations are generated largely by a "cytosolic oscillator" and are modified by the influx of Ca2+ across the surface membrane.
Nicholls
J A
JA
Department of Physiological Sciences, Medical School, The University, Newcastle upon Tyne, UK.
Greenwell
J R
JR
Gillespie
J I
JI
D002118:Calcium / Q000378:metabolism*; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D006632:Histamine / Q000494:pharmacology*; D006801:Humans; D007294:Inositol / Q000494:pharmacology; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D009543:Nifedipine / Q000494:pharmacology; D013849:Thimerosal / Q000494:pharmacology; D013997:Time Factors; D014700:Verapamil / Q000494:pharmacology
D013849:Thimerosal; D007294:Inositol; D006632:Histamine; D014700:Verapamil; D009543:Nifedipine; D002118:Calcium